The Archive · 1 posts
Revolutionising how we fight infections! 🚀 Ondine Biomedical Inc. (OBI) leads with innovative photodisinfection solutions. 🌟
Ondine Biomedical reports 2025 results: revenue up 29% but $30m loss as Phase 3 LANTERN trial enrolment completes. Top-line data due Spring 2026 – a key catalyst for Steriwave US approval.
June 4, 2026
Showing 0 of 1 posts